Skip to content

Welcome to Discover Pharma! Today is : November 18, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

drug discovery

  • Drug Discovery & Development,Research & Development

    Nuclera and Cambridge researchers produce GPCR structure in four days using cell-free technology

    Nuclera and University of Cambridge researchers have demonstrated a four-day [...]

    November 17, 2026
  • Digital & Data

    Causaly launches AI platform to support scientific work across drug development

    November 17, 2026
  • Biotech & Pharma Business,Central Nervous System,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Biogen partners with TRIMTECH on neurodegenerative disease protein degraders

    Biogen has entered a research collaboration with TRIMTECH Therapeutics to [...]

    November 16, 2026
  • Medical devices,Research & Development

    PlaqueTec expands coronary artery disease trial to eight NHS centres

    PlaqueTec has recruited 100 patients into its BIOPATTERN trial, which [...]

    November 13, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    PsiThera raises $25M to advance oral TNFα and TL1A drugs

    PsiThera has raised $25 million to advance oral TNFα and [...]

    November 10, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Research & Development

    AbbVie expands Oxford R&D with new research facility

    AbbVie has opened a new 12,000-square-foot Oxford research facility to [...]

    November 6, 2026
  • Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Nobel Prize in Chemistry 2026 recognises discoveries in asymmetric synthesis

    Henri B Kagan and Kenso Soai have been awarded the [...]

    November 2, 2026
  • Research & Development,Therapeutic Areas

    Lab-grown human neuromuscular junctions advance MND drug discovery

    UK biotech Myomaker Bio has developed lab-grown human neuromuscular junctions [...]

    October 7, 2026
  • Digital & Data,Drug Discovery & Development,Research & Development

    Shift Bioscience publishes AI virtual cell framework for target discovery

    Shift Bioscience has published research in Nature Biotechnology describing a [...]

    October 6, 2026
  • Biotech & Pharma Business,Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Ariadne Bio launches with Parkinson’s apathy drug candidate

    Ariadne Bio has launched with funding from The Michael J [...]

    September 18, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neurizon advances NUZ-001 ALS trial into treatment extension
    Categories: Clinical & Regulatory
  • ViiV HIV medicines receive positive EU opinion for younger children
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Ofichem agrees to acquire US CDMO Kinentia Biosciences
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Manufacturing & Supply Chain
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top